Sens. Scrutinize Murky Drug Pricing, Rebate Deals
U.S. senators on Tuesday sharply questioned whether opaque arrangements between drugmakers and pharmacy benefit managers are driving up drug costs....To view the full article, register now.
Already a subscriber? Click here to view full article